Cargando…
TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform
[Image: see text] The COVID-19 pandemic has highlighted the need for new antiviral approaches because many of the currently approved drugs have proven ineffective against mitigating SARS-CoV-2 infections. The host transmembrane serine protease TMPRSS2 is a promising antiviral target because it plays...
Autores principales: | Peiffer, Amanda L., Garlick, Julie M., Wu, Yujin, Wotring, Jesse W., Arora, Sahil, Harmata, Alexander S., Bochar, Daniel A., Stephenson, Corey J., Soellner, Matthew B., Sexton, Jonathan Z., Brooks, Charles L., Mapp, Anna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237299/ https://www.ncbi.nlm.nih.gov/pubmed/37284689 http://dx.doi.org/10.1021/acsmedchemlett.3c00035 |
Ejemplares similares
-
TMPRSS2 inhibitor discovery facilitated through an in silico and biochemical screening platform
por: Peiffer, Amanda L., et al.
Publicado: (2021) -
Allostery in the dynamic coactivator domain KIX occurs through minor conformational micro-states
por: Peiffer, Amanda L., et al.
Publicado: (2022) -
In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs
por: Chan, Wallace K. B., et al.
Publicado: (2022) -
Formal Cycloadditions Driven by the Homolytic Opening of Strained, Saturated Ring Systems
por: Harmata, Alexander S., et al.
Publicado: (2022) -
In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19
por: Wang, Shuo, et al.
Publicado: (2022)